首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 製藥 > 精神病 > 躁鬱症:躁鬱症人口的增加
產業/市場分類
製藥 (4816)
肥胖症治療 (44)
非專利藥 (129)
疫苗 (181)
神經疾病 (172)
骨頭疾病治療 (37)
動物用醫藥 (17)
處方藥 (156)
規章 (126)
感染疾病 (346)
精神病 (84)
製藥企業 (524)
糖尿病 (191)
癌症 (909)
藥物開發 (1449)
DDS (182)
OTC 非處方藥 (150)
市場調查報告書

躁鬱症:躁鬱症人口的增加

Epidemiology: Bipolar Disorders - Population growth to mean more patients with bipolar disorders

出版商 Datamonitor
出版日期 2011年07月 商品編碼 206497
內容資訊 英文 Pages: 39
價格
US $ 5700 PDF by E-mail (Single user license)
US $ 14250 PDF by E-mail (Global license)


躁鬱症:躁鬱症人口的增加 是由出版商Datamonitor在2011年07月所出版的。 這份英文市場調查報告書包含Pages: 39 價格從美金5700起跳。

簡介

2010年的全球7大市場中躁鬱症的獎勵件數有850萬件、其半數約發生在美國。發病率今後仍持續上升。

本報告書內容包括:今後10年的躁鬱症之免疫學預測、躁鬱症的危險因素等彙整、內容綱要摘記如下:

概要

實施摘要

疾病的定義和診斷基準

  • 躁鬱症的定義
  • 診斷基準
  • 事件的概要:躁鬱症事件的長度和種類

全球的趨勢和歷史的趨勢

  • 新設定的躁鬱症定義使得資料可以比較
  • 全球的趨勢:全球的發病率顯著的不同
  • 歷史的趨勢:躁鬱症的發病率今後仍持續上升
    • 發病率:壽命和12個月發病率的再發提升之比較可能
    • 發生率:躁鬱症的傳統型測定法
    • 死亡率:躁鬱症與自殺風險程度的相關

躁鬱症的免疫學促進因素

  • 危險因素
    • 家族歴
    • 年齡
    • 社會性變動
  • 共存症
    • 認知障害
    • 注意缺陷過活動障礙
    • 不安症
    • 酒精依賴症
    • 不法藥物的使用
  • 其他因素

躁鬱症的免疫學預測

  • 概要
  • 子群組
    • 年齡
    • 認識障礙
    • 美國
    • 日本
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 英國

免疫學的結果

  • 躁鬱症的發病率預測和未來趨勢

考察

參考資訊

附錄

圖表

目錄

Product Description

Introduction

In this analysis, Datamonitor estimates that there were a total of 8.5 million cases of bipolar disorders in 2010 in the seven major markets, with nearly half of these cases present in the US. Prevalence rates for bipolar disorders are expected to remain constant; therefore, any changes in prevalence will depend on population dynamics in the seven major healthcare markets.

Features And Benefits

• Gain insight into market potential, including a robust 10-year epidemiology forecast of prevalent bipolar disorder cases.
• Understand the key epidemiologic risk factors associated with bipolar disorders.

Highlights

Datamonitor expects an increase in prevalent bipolar disorder cases through to 2020 in the seven major markets as a result of population growth.

Mood disorders can cause severe distress as well as social, interpersonal, and occupational impairment.

Your Key Questions Answered

• What are the most robust epidemiologic studies for bipolar disorder prevalence data?
• How will the patient population change through to 2020 in the US, Japan, and the five major EU markets (France, Germany, Italy, Spain, and the UK)?
• How do changes in population structure and risk factors affect the trend in prevalent bipolar disorder cases?

Table of Contents

Executive Summary
   Prevalent numbers of bipolar disorder patients to be driven by population growth
OVERVIEW
   Catalyst
   Summary
DISEASE DEFINITION AND DIAGNOSIS CRITERIA
   Definition of bipolar disorders
   Diagnostic criteria
   Episodes description: length and type of bipolar disorder episodes
GLOBAL VARIATION AND HISTORICAL TRENDS
   Newly established bipolar disorder definition enables data comparability
   Global variation: no marked differences in prevalence rates across the globe
   Historical trend: temporal prevalence of bipolar disorders has remained constant
      Prevalence: lifetime and 12-month prevalence are comparable due to high recurrence
      Incidence: an unconventional measurement of bipolar disorders
      Mortality: bipolar disorders are associated with a high risk of suicide
DRIVERS OF BIPOLAR DISORDER EPIDEMIOLOGY
   Risk factors
      Family history: most evident risk factor
      Age: onset is most common in adolescence and early adulthood
      Social variables: life events
   Co-morbidities alter bipolar disorder epidemiology
      Cognitive impairment: a long-term disability that occurs in parallel with bipolar disorders
      Attention deficit hyperactivity disorder: highest co-occurrence with bipolar disorders in the youngest children
      Anxiety disorders: obsessive compulsive disorder, generalized anxiety, and panic disorders
      Alcohol dependence: highly co-morbid with bipolar disorders
      Illicit drug use: negatively impacts treatment
   Other factors: co-morbid medical conditions
EPIDEMIOLOGIC FORECASTING OF BIPOLAR DISORDERS
   Overview
      Sources of epidemiologic data
      Description of methods
   Subpopulations
      Age
      Cognitive impairment
      US
      Japan
      France
      Germany
      Italy
      Spain
      UK
EPIDEMIOLOGIC RESULTS
   Estimated prevalent cases of bipolar disorders and future trends
      Segmentation of prevalent cases
DISCUSSION
   Strengths and limitations
BIBLIOGRAPHY
   Journal papers
   Websites

Appendix

   Report methodology
Back to Top